Drug Facts Active Ingredient (In Each Tablet)
Meclizine HCl, USP 12.5 mg
The following Structured Product Label (SPL) was submitted to the FDA by Rising Pharma Holdings, Inc. for the product Meclizine Hcl (NDC 57237-333). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding drug facts active ingredient (in each tablet), purpose, uses, warnings, when using this product, otc - pregnancy or breast feeding, otc - keep out of reach of children, directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Meclizine HCl, USP 12.5 mg
Antiemetic
prevents and treats nausea, vomiting or dizziness associated with motion sickness.
Do not use in children under 12 years of age unless directed by a doctor.
Do not take this product, unless directed by a doctor, if you have
Do not take this product if you are
taking sedatives or tranquilizers, without first consulting your doctor.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
dosage should be taken one hour before travel starts
| adults and children 12 years and over | take 2 or 4 tablets once daily or as directed by a doctor |
colloidal silicon dioxide, crospovidone, lactose monohydrate, magnesium stearate, microcrystalline cellulose
Call 1-844-474-7464 Monday to Friday 8 AM - 5 PM ET
Manufactured by:
Unique Pharmaceutical Laboratories
(A Div. of J.B.Chemicals &
Pharmaceuticals Ltd.),
Mumbai 400 030, India
Mfg. Lic. No.: G/1430
Distributed by:
Rising Pharma Holdings, Inc.
East Brunswick, NJ 08816
Issued: 02/2024
138528
* Please review the disclaimer below.